Firas Saker, MD

In addition to his clinical practice, Dr. Saker is a member of several professional organizations, including the American Academy of Pediatrics, section of perinatal medicine. Dr. Saker chairs on several committees at Cleveland Clinic Children’s including the NICU Pharmacy & Therapeutic committee, the Neonatal Enterprise Quality committee, Hillcrest NICU operation, performance improvement and code pink committees; in addition to serving on several other committees such as the Cleveland Clinic Children's Quality Council committee. Among others.

• An established clinical researcher, Dr. Saker has secured a number of grants for his work and has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings.
• Dr. Saker was recently awarded a postgraduate medical certificate in Safety, Quality, Informatics, and Leadership (SQUIL) from Harvard Medical School (2024-2025).
• Dr.Saker serves as the chair for Safety, Quality and Patient Experience (SQPE) for neonatal care at the neonatal intensive care units and delivery room services across Cleveland Clinic enterprise.

Dr. Saker has received a number of awards and recognitions. Most recently he was selected by his colleagues to be included in the Best Doctor's list in America for the last 10 years in a raw; he also received a Lifetime Service Award from the Syrian American Medical Society. The Nightingale Physician Collaboration Award from the Cleveland Clinic Institute of Nursing and the FDR March of Dime community award

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-01-02, Dr. Saker has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.